Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
S&S Healthcare HoldingROCO:4198 +2.95%54 PS Ratio is 4.94 as of Jul. 28, 2026, which is 63% above its 10-year median of 3.04. GuruFocus rates ROCO:4198 with a GF Score™ of 54/100 and a GF Value™ of NT$23.57 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 803 Medical Devices & Instruments companies, S&S Healthcare Holding ranks worse than 69.36% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, S&S Healthcare Holding's share price is NT$41.90.
S&S Healthcare Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$8.49. Hence, S&S Healthcare Holding's PS Ratio for today is 4.94.
The historical rank and industry rank for S&S Healthcare Holding's PS Ratio or its related term are showing as below:
ROCO:4198'
s PS Ratio Range Over the Past 10 Years
Min: 0.6 Med: 3.04 Max: 9.67
Current: 4.93
During the past 13 years, S&S Healthcare Holding's highest PS Ratio was 9.67. The lowest was 0.60. And the median was 3.04.
ROCO:4198's PS Ratio is ranked worse than 69.36% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.89
vs ROCO:4198: 4.93
S&S Healthcare Holding Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of S&S Healthcare Holding was -15.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -16.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 1.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -20.50% per year.
During the past 13 years, S&S Healthcare Holding's highest 3-Year average Revenue per Share Growth Rate was 10.20% per year. The lowest was -46.70% per year. And the median was -14.25% per year.
Back to Basics: PS Ratio
S&S Healthcare Holding (ROCO:4198) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, S&S Healthcare Holding's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S&S Healthcare Holding PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S&S Healthcare Holding's PS Ratio distribution charts can be found below:
* The bar in red indicates where S&S Healthcare Holding's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
S&S Healthcare Holding's Share Price of today is NT$41.90. S&S Healthcare Holding's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$8.49.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
S&S Healthcare Holding (ROCO:4198) has a PS Ratio of 4.94 as of Jul. 28, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on S&S Healthcare Holding and its competitors. This is 63% above median its historical median of 3.04. Over the past decade, S&S Healthcare Holding's PS Ratio has ranged from 0.60 to 9.67. According to the industry distribution chart, S&S Healthcare Holding ranks #557 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 69.4%.
Is S&S Healthcare Holding's PS Ratio too high?
S&S Healthcare Holding's current PS Ratio of 4.94 is 63% above median its 10-year median of 3.04. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 9.67. The Medical Devices & Instruments industry median PS Ratio is 2.89. S&S Healthcare Holding's value of 4.94 is 70.9% above this industry median. Based on the distribution chart, S&S Healthcare Holding ranks #557 out of 803 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, S&S Healthcare Holding has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does S&S Healthcare Holding's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, S&S Healthcare Holding ranks #557 out of 803 companies for PS Ratio. This places S&S Healthcare Holding in the lower half of its industry. The industry median PS Ratio is 2.89. S&S Healthcare Holding's value of 4.94 is 70.9% above this benchmark. Historically, S&S Healthcare Holding's own PS Ratio has ranged from 0.60 to 9.67 over the past decade. While the company's 10-year median is 3.04 vs. the industry median of 2.89, S&S Healthcare Holding has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.89, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. S&S Healthcare Holding's current PS Ratio of 4.94 is 70.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on S&S Healthcare Holding and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S&S Healthcare Holding's current PS Ratio is 4.94, which is 63% above median its own 10-year median of 3.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S&S Healthcare Holding stock overvalued right now?
Based on GuruFocus' analysis, S&S Healthcare Holding (ROCO:4198) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$23.57, compared to a current price of NT$41.90 — trading 77.8% above its estimated fair value. The current PS Ratio is 4.94, which is 63% above median its 10-year median of 3.04 and 70.9% above the Medical Devices & Instruments industry median of 2.89. S&S Healthcare Holding's overall GF Score™ is 54/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For S&S Healthcare Holding (ROCO:4198), the current PS Ratio is 4.94 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is S&S Healthcare Holding (ROCO:4198) Overvalued in 2026?
Based on GuruFocus' analysis, S&S Healthcare Holding stock appears to be overvalued.
The current stock price of NT$41.90 is trading 77.8% above its estimated GF Value™ of NT$23.57.
GuruFocus considers S&S Healthcare Holding to be Significantly Overvalued.
Key valuation signals for ROCO:4198:
PS Ratio: 4.94 (63% above median its 10-year median of 3.04)
GF Value™: NT$23.57 vs. price of NT$41.90 (77.8% above fair value)
Industry Position: 70.9% above the Medical Devices & Instruments median (#557 of 803)
No single metric tells the full story. See the ROCO:4198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
S&S Healthcare Holding Ltd, formerly Swissray Global Healthcare Holding Ltd is involved in providing DR systems designed for any application in general radiography. The product divisions of the company cover Swissray DDR systems, Novadaq, and EZ2GO. The main business projects of the company and its subsidiaries are the research and development, manufacturing, sales, and maintenance services of high-end medical equipment and the manufacturing and sales of basic medical equipment.
54GF Score
Get the complete analysis for ROCO:4198
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4198 has been successfully added to your 
